PRCTPROCEPT BioRobotics Corporation

$18.40-51% 1Y

Is it safe?

Watch

Mixed picture: a safe balance sheet and clean books, but quality weak and heavy debt (BB).

3 good, 3 to watch
SurvivalSafe zone

Financially healthy, low distress risk Altman Z-score, a bankruptcy-risk model from five balance-sheet ratios.

Honest booksLow risk

Reported earnings show no manipulation flags Beneish M-score, a forensic model that detects earnings-manipulation patterns (receivables outrunning sales, margins slipping, accrual-heavy profit).

Quality3 / 9

Weak, deteriorating fundamentals Piotroski F-score, nine pass/fail tests of year-over-year financial health across profitability, balance sheet and efficiency. 7 to 9 is strong, 0 to 3 weak.

Insider conviction+$476K

Insiders were net buyers (+$476K, 90 days to Oct 8, 2026). SEC Form 4 filings: officers and directors must report their own trades within two business days.

Credit gradeBBderived · Jun 30, 2026

Net cash, but unprofitable, speculative. A rule of thumb on leverage, not a credit rating.

Drawdown risk62% volderived · Oct 9, 2026

Large price swings, high volatility. Worst drawdown -83% · now 53% below its 52-week high.

Unless marked, from SEC EDGAR, as of Dec 31, 2025.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Volatilitybehind 79% of the market
Max drawdownbehind 79% of the market

Where this answer is blind. Altman sits structurally low for utilities and pipelines; Beneish runs high for fast growers, since sales growth alone lifts it; banks and REITs are excluded.

Can PRCT take a bad year?

PROCEPT BioRobotics Corporation holds $176M more cash than debt, and is burning $21M a quarter, about 2.7 years of cover.

$176M

Net cash

Net debt / EBITDA
net cash

Net debt / EBITDA · no net borrowings to measure against earnings

Altman Z-score
4.23

Altman Z-score · safe zone, above 3

Cash runway
2.7 years

Cash runway · burning $21M a quarter at the current rate

Details›
Total debtQ2 2026
$52M
Cash and short-term investments
$228M
Net cash
$176M
EBITDA, trailing twelve months
−$107M
Operating profit, trailing twelve months
−$114M
Debt / equity
0.15×
Annualised volatilitytwo years of daily moves
62%
Worst drawdown on file
−83%
Below its 52-week high
53%

Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.

On our screens:Most shorted stocks